Rise Therapeutics

company

About

Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$200K
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. Rise leverages its target discovery expertise to understand microbiome gut biology as it relates to regulation of immune function.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$200K
Rise Therapeutics has raised a total of $200K in funding over 2 rounds. Their latest funding was raised on Dec 5, 2017 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 5, 2017 Seed $200K 1 TEDCO Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Rise Therapeutics is funded by 1 investors. TEDCO are the most recent investors.
Investor Name Lead Investor Funding Round
TEDCO Yes Seed